May. 5 at 8:49 PM
$LMAT Q1 '26 Earnings Results & Recap
• Reported GAAP EPS of
$0.69 up 40.82% YoY
• Reported revenue of
$66.55M up 11.16% YoY
• Lemaitre Vascular expects full year 2026 sales to be between
$277MM and
$283MM, representing 12% organic growth, with EPS projected to be
$2.93 to
$3.08, reflecting 19% growth.
